Yinfeng Yang | Artificial Intelligence |Young Scientist Award

Assoc. Prof. Dr. Yinfeng Yang | Artificial Intelligence | Young Scientist Award

Anhui University of Chinese Medicine | China

Assoc. Prof. Dr. Yinfeng Yang is an Associate Professor and emerging research leader at the intersection of artificial intelligence and traditional Chinese medicine, with a strong focus on biomedical big data analytics and AI-driven drug discovery. With a publication record of 45 documents and a citation impact exceeding 5,738 citations from 5,599 citing documents, alongside an h-index of 18, her research demonstrates significant international influence. Her work integrates bioinformatics, machine learning, molecular simulation, and systems biology to uncover key biomarkers, elucidate disease mechanisms, and accelerate the development of innovative therapeutic strategies. She has made notable contributions to multi-omics data mining, virtual screening, quantitative structure–activity relationship modeling, and mechanistic analysis of natural products and traditional prescriptions, particularly in oncology, immunology, cardiovascular disorders, and neurological diseases. Her research advances include AI-powered ADMET prediction, graph neural network–based drug-target discovery, and multiscale modeling of herbal medicine mechanisms. She has authored more than sixty publications, including first- and corresponding-author papers in high-impact journals such as Journal of Advanced Research, Phytomedicine, Drug Discovery Today, International Journal of Surgery, and ACS Omega, contributing influential and highly cited work. In addition to her scientific output, she has edited scholarly works, holds an authorized patent, and has received provincial recognition for scientific achievements. She also serves on editorial boards and contributes extensively as a reviewer for numerous international journals across pharmacology, bioinformatics, natural product research, and integrative medicine. Her expertise spans molecular dynamics, docking, high-throughput virtual screening, AI algorithms, multi-omics integration, and experimental pharmacology, positioning her at the forefront of intelligent medicine and translational research in traditional Chinese medicine.

Featured Publications

  • Fan, N. N., Chen, J., Wang, J. H., Chen, Z. S., & Yang, Y. F. (2025). Bridging data and drug development: Machine learning approaches for next-generation ADMET prediction. Drug Discovery Today, Article 104487.

  • Han, Z. J., Liu, Q. W., Yang, J. H., Wang, X. Y., Song, W. C., Wang, J. H., & Yang, Y. F. (2025). Exploration of the mechanism of Ginkgo biloba leaves targeted angiogenesis against gastric cancer. ACS Omega, 10, 40460–40476.

  • Yang, P. Z., Wang, X. Y., Yang, J. H., Yan, B. B., Sheng, H. Y., Li, Y., Yang, Y. F., & Wang, J. H. (2025). AI-driven multiscale study on the mechanism of Polygonati Rhizoma in regulating immune function in STAD. ACS Omega, 10(19), 19770–19796.

  • Li, H., Fu, S. F., Shen, P., Zhang, X., Yang, Y. F., & Guo, J. C. (2025). Mitochondrial pathways in rheumatoid arthritis: Therapeutic roles of traditional Chinese medicine and natural products. Phytomedicine, Article 157106.

  • Zhang, H. R., Xu, Q., Kan, H. X., Yang, Y. F., & Cai, Y. Q. (2025). Exploration of the clinicopathological and prognostic significance of BRCA1 in gastric cancer. Discover Oncology, 16(1), 381.